We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bill Provides Temporary Band-Aid For Generic Exclusivity Forfeiture
Bill Provides Temporary Band-Aid For Generic Exclusivity Forfeiture
April 6, 2012
As the FDA’s backlog of ANDAs continues to grow, it’s become increasingly common for generic-drug makers to lose their 180-day exclusivity by not gaining timely tentative approval.